| Author/Editor | Kragelj, Borut; Zaletel-Kragelj, Lijana | |
| Title | Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer | |
| Type | članek | |
| Source | Radiother Oncol | |
| Vol. and No. | Letnik 102, št. 3 | |
| Publication year | 2012 | |
| Volume | str. 412-5 | |
| Language | eng | |
| Abstract | Tolerability to gemcitabine radiochemotherapy was evaluated in 33 patients with inoperable, locally advanced transitional-cell bladder cancers. The dose of 75 mg/m2 gemcitabine once a week, concurrently with standard radiotherapy of 60 Gy/6 weeks, was found to be acceptable. Eighty-one percentage of 3-year local progression-free survival suggests efficiency warranting further studies. | |
| Descriptors | BLADDER NEOPLASMS |